SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,427,550 | +92.9% | 307,000 | +241.2% | 0.34% | +48.3% |
| Q1 2022 | $740,000 | -92.7% | 89,980 | -86.8% | 0.23% | -89.3% |
| Q4 2021 | $10,118,000 | -0.4% | 680,000 | +26.4% | 2.15% | +13.1% |
| Q3 2021 | $10,159,000 | +10.0% | 537,800 | +8.2% | 1.90% | +23.7% |
| Q2 2021 | $9,237,000 | +18.7% | 496,900 | +45.3% | 1.53% | +34.2% |
| Q1 2021 | $7,783,000 | +11.3% | 341,950 | +6.1% | 1.14% | +25.1% |
| Q4 2020 | $6,995,000 | +376.8% | 322,200 | +120.7% | 0.91% | +218.5% |
| Q3 2020 | $1,467,000 | – | 146,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |